imbruvica comprimé
janssen inc - ibrutinib - comprimé - 420mg - ibrutinib 420mg - antineoplastic agents
imbruvica comprimé
janssen inc - ibrutinib - comprimé - 560mg - ibrutinib 560mg - antineoplastic agents
imbruvica suspension
janssen inc - ibrutinib - suspension - 70mg - ibrutinib 70mg
calquence capsule
astrazeneca canada inc - acalabrutinib - capsule - 100mg - acalabrutinib 100mg - antineoplastic agents
calquence comprimé
astrazeneca canada inc - acalabrutinib (maléate d¿acalabrutinib) - comprimé - 100mg - acalabrutinib (maléate d¿acalabrutinib) 100mg
venclexta comprimé
abbvie corporation - venetoclax - comprimé - 10mg - venetoclax 10mg - antineoplastic agents
venclexta comprimé
abbvie corporation - venetoclax - comprimé - 50mg - venetoclax 50mg - antineoplastic agents
venclexta trousse
abbvie corporation - venetoclax; venetoclax; venetoclax - trousse - 10mg; 50mg; 100mg - venetoclax 10mg; venetoclax 50mg; venetoclax 100mg - antineoplastic agents
venclexta comprimé
abbvie corporation - venetoclax - comprimé - 100mg - venetoclax 100mg - antineoplastic agents
arzerra solution
novartis pharmaceuticals canada inc - ofatumumab - solution - 100mg - ofatumumab 100mg - antineoplastic agents